These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

847 related articles for article (PubMed ID: 33516602)

  • 21. Emergency Use Authorizations (EUAs) Versus FDA Approval: Implications for COVID-19 and Public Health.
    Zuckerman DM
    Am J Public Health; 2021 Jun; 111(6):1065-1069. PubMed ID: 33950730
    [No Abstract]   [Full Text] [Related]  

  • 22. Placebo-controlled trials with COVID-19 vaccines: participants first.
    Dal-Ré R
    J Clin Epidemiol; 2021 Oct; 138():211-212. PubMed ID: 34271109
    [No Abstract]   [Full Text] [Related]  

  • 23. The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021.
    Mbaeyi S; Oliver SE; Collins JP; Godfrey M; Goswami ND; Hadler SC; Jones J; Moline H; Moulia D; Reddy S; Schmit K; Wallace M; Chamberland M; Campos-Outcalt D; Morgan RL; Bell BP; Brooks O; Kotton C; Talbot HK; Lee G; Daley MF; Dooling K
    MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(44):1545-1552. PubMed ID: 34735422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Casirivimab and imdevimab (REGEN-COV) for post-exposure prophylaxis of COVID-19.
    Med Lett Drugs Ther; 2021 Aug; 63(1631):130-131. PubMed ID: 34544100
    [No Abstract]   [Full Text] [Related]  

  • 25. The US Regulatory System and COVID-19 Vaccines: The Importance of a Strong and Capable FDA.
    Sharfstein JM; Goodman JL; Borio L
    JAMA; 2021 Mar; 325(12):1153-1154. PubMed ID: 33587124
    [No Abstract]   [Full Text] [Related]  

  • 26. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.
    Woodworth KR; Moulia D; Collins JP; Hadler SC; Jones JM; Reddy SC; Chamberland M; Campos-Outcalt D; Morgan RL; Brooks O; Talbot HK; Lee GM; Bell BP; Daley MF; Mbaeyi S; Dooling K; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(45):1579-1583. PubMed ID: 34758012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.
    Pawlowski C; Lenehan P; Puranik A; Agarwal V; Venkatakrishnan AJ; Niesen MJM; O'Horo JC; Virk A; Swift MD; Badley AD; Halamka J; Soundararajan V
    Med; 2021 Aug; 2(8):979-992.e8. PubMed ID: 34223401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Audio Interview: Covid-19 Vaccine Fundamentals.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Dec; 383(25):e146. PubMed ID: 33326722
    [No Abstract]   [Full Text] [Related]  

  • 30. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2021 FDA approvals: value driven by COVID-19 vaccines.
    Baedeker M; Ringel MS; Schulze U
    Nat Rev Drug Discov; 2022 Feb; 21(2):90. PubMed ID: 35039671
    [No Abstract]   [Full Text] [Related]  

  • 32. Communicating Effectively About Emergency Use Authorization and Vaccines in the COVID-19 Pandemic.
    Quinn SC; Jamison AM; Freimuth V
    Am J Public Health; 2021 Mar; 111(3):355-358. PubMed ID: 33237801
    [No Abstract]   [Full Text] [Related]  

  • 33. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021.
    MacNeil JR; Su JR; Broder KR; Guh AY; Gargano JW; Wallace M; Hadler SC; Scobie HM; Blain AE; Moulia D; Daley MF; McNally VV; Romero JR; Talbot HK; Lee GM; Bell BP; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):651-656. PubMed ID: 33914723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "When Will
    Bloom BR; Nowak GJ; Orenstein W
    N Engl J Med; 2020 Dec; 383(23):2202-2204. PubMed ID: 32897660
    [No Abstract]   [Full Text] [Related]  

  • 35. In brief: Pfizer/BioNTech COVID-19 vaccine authorized for adolescents 12-15 years old.
    Med Lett Drugs Ther; 2021 May; 63(1625):81. PubMed ID: 34101717
    [No Abstract]   [Full Text] [Related]  

  • 36. Emergency Use Authorization of COVID-19 Vaccine: Implications for Worker Communities.
    Culp K; Dukes KC; Cowin C; Sinnwell E
    Workplace Health Saf; 2021 Apr; 69(4):152-153. PubMed ID: 33787400
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021.
    Dooling K; Gargano JW; Moulia D; Wallace M; Rosenblum HG; Blain AE; Hadler SC; Plumb ID; Moline H; Gerstein J; Collins JP; Godfrey M; Campos-Outcalt D; Morgan RL; Brooks O; Talbot HK; Lee GM; Daley MF; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1344-1348. PubMed ID: 34555007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Answering Key Questions About COVID-19 Vaccines.
    Goodman JL; Grabenstein JD; Braun MM
    JAMA; 2020 Nov; 324(20):2027-2028. PubMed ID: 33064145
    [No Abstract]   [Full Text] [Related]  

  • 39. In brief: Third dose of mRNA-based COVID-19 vaccines for immunocompromised persons.
    Med Lett Drugs Ther; 2021 Sep; 63(1633):145-146. PubMed ID: 34550960
    [No Abstract]   [Full Text] [Related]  

  • 40. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021.
    Wallace M; Woodworth KR; Gargano JW; Scobie HM; Blain AE; Moulia D; Chamberland M; Reisman N; Hadler SC; MacNeil JR; Campos-Outcalt D; Morgan RL; Daley MF; Romero JR; Talbot HK; Lee GM; Bell BP; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(20):749-752. PubMed ID: 34014913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.